ロード中...

Impact of nicorandil in angina: subgroup analyses

Aims: IONA (impact of nicorandil in angina) is a randomised, double blind, placebo controlled trial of nicorandil, with a target dose of 20 mg twice daily. The consistency of benefits seen in subgroups is reported. Methods: The primary composite end point of the study was coronary heart disease deat...

詳細記述

保存先:
書誌詳細
フォーマット: Artigo
言語:Inglês
出版事項: Copyright 2004 by Heart 2004
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC1768587/
https://ncbi.nlm.nih.gov/pubmed/15547020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2003.026310
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!